Diabetologia, the journal of the EASD, currently has a series of four papers and an Editorial

in print, all relating to a possible link between insulin glargine (Lantus insulin) and cancer.

EASD advises that patients do not stop taking insulin glargine based upon the information presented on this website. If you wish to have further information you should contact your

doctor. 

Advance copies of the papers and relevant patient information can be downloaded by

following the links below. 

These studies are described and commented on in greater detail in the attached webcast by Professor Ulf Smith (University of Göteborg, Sweden), and Professor Edwin Gale (University

of Bristol, UK).

EASD emphasises that the studies reported are far from conclusive, but they do indicate the need for further investigation of this issue.

The transcript of the statement by Professor Smith and Professor Gale is available here: Transcript

Papers: